The CCL-2 plasma level showed a trend similar to VEGF: Higher in NR vs R patients, but significantly higher only between NR and healthy controls ( P = 0.035).
← all excerpts
Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib.
1
—
—